As of April Debby Gerritsen of the Department of Primary and Community Care has been appointed full professor ‘Well-being of frail elderly people and people with a chronic illness in long-term care’.The chair, financed by the UKON, is a stimulus for the attention to well-being in this setting, where personal self-management skills are used as much as possible. As professor, Debby will focus on initiating and supervising scientific research, the education of researchers and co-shaping multidisciplinary networks such as research and innovation infrastructure, in particular the UKON. A specific point of attention will be the outlining of the elderly psychologist as an important factor of innovation in long-term care. Together with her colleagues, Debby focuses on questions that arise from the clinical practice of long-term care, such as the development, evaluation and implementation of interventions. The applied research methods are innovative and appropriate to the complex reality of daily practice. Evaluations of implementation processes are also a goal, based on the experience that implementing and maintaining innovations in long-term care deserve attention. Debby: "This focus on evaluation of implementation fits perfectly with the UKON, where implementation is one of its cornerstones".
Debby Gerritsen is member of theme Healthcare improvement science.
Related news items
Radboudumc Master Prize for Mark van Goor18 June 2019
Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.read more
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies18 June 2019
Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more